Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
Absorption, Physiological
Antiviral Agents
/ chemistry
Catalytic Domain
Drug Development
Drug Elimination Routes
Enzyme Inhibitors
/ chemistry
Hepacivirus
/ drug effects
Humans
Models, Biological
Molecular Docking Simulation
Phytochemicals
/ chemistry
Protein Binding
Tissue Distribution
Viral Nonstructural Proteins
/ antagonists & inhibitors
Journal
Pakistan journal of pharmaceutical sciences
ISSN: 1011-601X
Titre abrégé: Pak J Pharm Sci
Pays: Pakistan
ID NLM: 9426356
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
9
4
2021
pubmed:
10
4
2021
medline:
19
11
2021
Statut:
ppublish
Résumé
Hepatitis C virus (HCV) has major role in spreading of liver diseases worldwide. The HCV nonstructural NS5B is a polymerase (RdRp) that is present at the carboxylic-end of the polyprotein chain. It is essential and most important for the replication cycle. In current study, the potential of 100 phytochemicals against HCV NS5B polymerase was determined. Phytochemical structures were retrieved from PubChem database. The phytochemicals were docked with the NS5B active site amino acids, in order to discover their attractions as inhibitors. After docking, molecules with top five conformations were selected from 100 molecules by docking scores and RMSD values. The results demonstrated strong interactions of phytochemicals with the NS5B. The selected compounds with best docking scores and RMSD were found to be glycitein, ferulic acid, eugenol, 1-octanol and sebacic acid. These were further evaluated through Lipinski's rule of five to explore their molecular properties and drug-likeliness characteristics and all five selected phytochemicals were found to have drug-likeliness characteristics. Further, according to ADME analysis, the ferulic acid, 1-octanol and eugenol were found to be nontoxic, non-carcinogenic and have the ability to cross the blood brain barriers. Therefore, these phytochemicals could be strong drug candidates for HCV NS5B.
Substances chimiques
Antiviral Agents
0
Enzyme Inhibitors
0
Phytochemicals
0
Viral Nonstructural Proteins
0
NS-5 protein, hepatitis C virus
EC 2.7.7.48
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM